EL
AUTL

EWA LLC’s Autolus Therapeutics AUTL Stock Holding History

EWA LLC’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,280
Closed -$35.9K – 183
2024
Q4 		$35.9K Sell
15,280
-1,427
-9% -$4.82K 0.01% 156
2024
Q3 		$50.3K Sell
16,707
-1,031
-6% -$4.11K 0.02% 161
2024
Q2 		$76.1K Sell
17,738
-6,562
-27% -$28.3K 0.03% 147
2024
Q1 		$97K Sell
24,300
-1,378
-5% -$8.6K 0.04% 131
2023
Q4 		$155K Buy
25,678
+7,361
+40% +$28.1K 0.08% 114
2023
Q3 		$67K Buy
+18,317
New +$52.2K 0.04% 96

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWA LLC's AUTL Position: Q1 2025 in Review

EWA LLC sold out of Autolus Therapeutics (AUTL) in Q1 2025, closing a stake of 15,280 shares — an estimated $35.9K sold.

EWA LLC first reported a position in AUTL in Q3 2023 and held it in 6 quarters. The position peaked at $155K in Q4 2023. 95 funds tracked by Wall St. Rank hold AUTL as of Q1 2025.

  • EWA LLC reported no remaining Autolus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • EWA LLC sold 15,280 Autolus Therapeutics shares in Q1 2025, an estimated $35.9K.
  • EWA LLC first reported a position in Autolus Therapeutics in Q3 2023 and held it in 6 quarters.
  • EWA LLC's Autolus Therapeutics position peaked at $155K in Q4 2023.
  • 95 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2025.

Based on EWA LLC's 13F filing for Q1 2025, filed 22 Apr 2025.